Science & Technology
Experimental ‘gene silencing’ therapy reduces lipoprotein(a), an important risk factor of heart disease, by up to 98%
Findings from a phase 1 trial show that an experimental ‘gene silencing’ therapy reduced blood levels of lipoprotein(a), a key driver of heart disease risk, by up to 98%.
Omicron ‘less severe’ than Delta for children ages 4 and younger, study suggests
New research suggests that the children younger than age 5 who are infected with the COVID-19 Omicron variant have less risk of severe health outcomes than those infected with the Delta variant.
New research shows survival rate improvement for extremely pre-term infants
A study conducted at 19 medical centers from 2013-2018 found that the survival rate of babies born at 22 weeks (30%) and 23 weeks (55.8%) had increased significantly compared to the same study conducted from 2008-2013, in which only 7% of babies born a…